India’s push for ‘Jan Vishwas’ faces a stark contradiction as authorities increasingly use stringent NDPS and BNS laws against licensed pharmaceutical stockists. Despite clear regulations under the Drugs and Cosmetics Act, businesses dealing in common cough syrups are being prosecuted, blurring lines between regulation and criminality. This trend risks eroding trust and undermining the rule of law.
Related Posts
कोण्डागांव: उरन्दाबेड़ा पुलिया निर्माण से बड़ी आबादी को मिल रही है आवागमन सुविधा
दूरस्थ ईलाके में शिक्षा-स्वास्थ्य सुविधाओं की पहुंच हुई आसान जिले के फरसगांव ब्लाक अंतर्गत उप तहसील मुख्यालय बड़ेडोंगर से उरन्दाबेड़ा-फुंडेर मार्ग पर उरन्दाबेड़ा स्थित बारदा […]
Omar’s ministers criss-cross states for safety of Kashmiris facing Pahalgam ‘backlash’
Following the Pahalgam terror attack, the J&K government has deployed ministers to various states to address reports of threats and attacks against Kashmiris. These ministers […]
Top stocks to buy today: Stock recommendations for February 28, 2025
Stock market recommendations: Bajaj Broking recommends SRF and Voltas as top stock picks citing technical analysis and breakout opportunities. Nifty may consolidate between 22,400-23,000 range […]